Navigation Links
United BioSource Acquires Leading Publication Planning Software and Services Company

BETHESDA, Md., April 15 /PRNewswire/ -- United BioSource Corporation (UBC) today announced the acquisition of Envision Pharma, a leading scientific communications and technology company based in Horsham, UK, with offices in Southport and Glastonbury, Conn. and Philadelphia, Pa. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications that contribute to marketplace awareness and comprehension of compounds at launch and beyond.

(Logo: )

UBC provides evidence-based solutions to support the development and commercialization of pharmaceuticals, biotechnology and medical devices. The acquisition of Envision Pharma expands the company's global presence and capability in the development and delivery of scientific communication.

Envision Pharma has two market-leading applications. Datavision(TM) is the pharmaceutical industry's premier application for developing and managing transparent, compliant publications programs. Used by over 30 companies with nearly 400 products, Datavision(TM) provides a platform for strategic planning and workflow management, while ensuring compliance and precision in the publications process. Visiontracker(TM), launched in 2007, offers management of independent investigator trials, supporting the process from application through to study completion for both the investigator and sponsor.

Envision Pharma combines its publications technology software with a global staff of experienced medical writers to support the planning and development of medical publications and other scientific communications for its pharmaceutical clients. The team also provides publication consultancy services to the industry, including the development of policies and processes that ensure optimal legislative and guideline adherence.

"We are thrilled to welcome the Envision team to the UBC family," says Ethan Leder, CEO of UBC. "Like UBC," Leder continues, "Envision combines strategically driven scientific and technology solutions for life sciences clients. Given the increasing demand of regulators and public opinion for transparency in research, Envision's contribution to the production of objective, scientifically driven medical publications is a cornerstone of our evidence-based credo and highly valuable to the entire medical community."

"Joining UBC helps us achieve our vision of bringing a more robust scientific offering to our clients faster than we could have on our own, with people of a similar mindset," notes Brian Hepburn, Envision Co-founder and General Manager.

"UBC's mission to build all of its services with a focus on evidence made UBC an ideal partner for Envision," says Dan Donovan, Envision Co-founder and Senior Vice President of Strategy and Market Development. Donovan adds, "Envision's mission is built around the notion that products developed with a solid evidence base will deliver the greatest impact and success for all stakeholders, from industry to healthcare and insurance providers, governments and patients."

Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries. Envision specializes in data dissemination and the effective application of smart technology. For further information on Envision Pharma visit .

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in providing new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Europe and South America. For more information, visit or call 866-458-1096.

+1 (240) 644-0420

SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genetic Engineering and Biotechnology News (GEN) Blog: International Students in the United States - A Diminishing Pool of Talent for Biotech?
2. HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO).
3. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
4. Moleac Launches NeuroAid10(TM) in the United States
5. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
6. United BioSource Expands Regulatory Affairs Capabilities
7. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
8. United States Patent Office Grants CryoCors Request for Patent Interference
9. United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 2008
10. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
11. Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Proove Biosciences, a ... their partnership with the Keck Medicine of the University of Southern California ... T.R.O.J.A.N. Study (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic Association ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
(Date:10/12/2015)... Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... engaged in developing and commercializing novel treatments in oncology, ... Dennis Turpin , the Company,s former Senior Vice ... its Quebec City office.  ... Chief Executive Officer of the Company commented, "After a ...
(Date:10/12/2015)... ... October 12, 2015 , ... Dr. Carl Peck, MD, Chairman ... firm as a Premier Expert consultant. NDA Partners Premier Experts are top ... to the company's clients. Premier Experts collaborate to design and implement critical ...
Breaking Biology Technology:
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to be ... its product to market. The official announcement was recently made ... event in San Francisco , where ... powered by IBM Watson. "It is both an ... 100 companies to bring to market the cognitive power of ...
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
(Date:9/28/2015)... , September 28, 2015 According ... (Hardware & Software), Product (Scanner & Others), Application (Access ... Defense, & Others) & Geography Global - Forecast to ... to reach USD 3627.90 Million by 2020, at a ... Browse 65 market data T ables and ...
Breaking Biology News(10 mins):